BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Habotta OA, Batiha GE. High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons. Inflammopharmacology 2022. [PMID: 35471628 DOI: 10.1007/s10787-022-00988-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Kuraishy HM, Batiha GE, Al-Gareeb AI, Al-Harcan NAH, Welson NN. Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon. Mol Cell Biochem 2023;:1-9. [PMID: 36652045 DOI: 10.1007/s11010-023-04658-7] [Reference Citation Analysis]
2 Tuculeanu G, Barbu EC, Lazar M, Chitu-Tisu CE, Moisa E, Negoita SI, Ion DA. Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19. J Clin Med 2023;12. [PMID: 36675530 DOI: 10.3390/jcm12020601] [Reference Citation Analysis]
3 Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Youssef FS, El-Sherbeni SA, Negm WA. A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection. Inflammopharmacology 2022;:1-11. [PMID: 36484974 DOI: 10.1007/s10787-022-01111-x] [Reference Citation Analysis]
4 Joshi AA, Wu Y, Deng S, Preston-hurlburt P, Forbes JM, Herold KC. RAGE antagonism with azeliragon improves xenograft rejection by T cells in humanized mice. Clinical Immunology 2022;245:109165. [DOI: 10.1016/j.clim.2022.109165] [Reference Citation Analysis]
5 Batiha GE, Al-kuraishy HM, Al-gareeb AI, Alruwaili M, Alruwaili R, Albogami SM, Alorabi M, Saad HM, Simal-gandara J. Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal. Inflammopharmacol 2022. [DOI: 10.1007/s10787-022-01087-8] [Reference Citation Analysis]
6 Mohamed Husien H, Peng W, Su H, Zhou R, Tao Y, Huang J, Liu M, Bo R, Li J. Moringa oleifera leaf polysaccharide alleviates experimental colitis by inhibiting inflammation and maintaining intestinal barrier. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1055791] [Reference Citation Analysis]
7 Giordano G, Teresa Bochicchio M, Niro G, Lucchesi A, Napolitano M. Genetic regulation of iron homeostasis in sideropenic patients with mild COVID-19 disease under a new oral iron formulation: Lessons from a different perspective. Immunobiology 2022;227:152297. [PMID: 36327544 DOI: 10.1016/j.imbio.2022.152297] [Reference Citation Analysis]
8 Al-Kuraishy HM, Al-Gareeb AI, Albezrah NKA, Bahaa HA, El-Bouseary MM, Alexiou A, Al-Ziyadi SH, Batiha GE. Pregnancy and COVID-19: high or low risk of vertical transmission. Clin Exp Med 2022. [PMID: 36251144 DOI: 10.1007/s10238-022-00907-z] [Reference Citation Analysis]
9 Zou C, Liu L, Huang C, Hu S. Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways. Front Pharmacol 2022;13:1018438. [DOI: 10.3389/fphar.2022.1018438] [Reference Citation Analysis]
10 Gomaa AA, Abdel-Wadood YA, Gomaa MA. Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment. Inflammopharmacology 2022. [PMID: 36136251 DOI: 10.1007/s10787-022-01062-3] [Reference Citation Analysis]
11 Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE. Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19. Biotechnol Genet Eng Rev 2022;:1-21. [PMID: 36098621 DOI: 10.1080/02648725.2022.2122290] [Reference Citation Analysis]
12 Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE. An insight into the placental growth factor (PlGf)/angii axis in Covid-19: a detrimental intersection. Biotechnol Genet Eng Rev 2022;:1-20. [PMID: 36096720 DOI: 10.1080/02648725.2022.2122291] [Reference Citation Analysis]
13 Holms RD. Long COVID (PASC) Is Maintained by a Self-Sustaining Pro-Inflammatory TLR4/RAGE-Loop of S100A8/A9 > TLR4/RAGE Signalling, Inducing Chronic Expression of IL-1b, IL-6 and TNFa: Anti-Inflammatory Ezrin Peptides as Potential Therapy. Immuno 2022;2:512-533. [DOI: 10.3390/immuno2030033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, Alorabi M, Hadi Al-Harcan NA, El-Bouseary MM, Batiha GE. Citicoline and COVID-19: vis-à-vis conjectured. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 36063198 DOI: 10.1007/s00210-022-02284-6] [Reference Citation Analysis]
15 Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, De Waard M, Sabatier JM, Saad HM, Batiha GE. The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not? Diagnostics (Basel) 2022;12:2051. [PMID: 36140453 DOI: 10.3390/diagnostics12092051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Al-Thomali AW, Al-Kuraishy HM, Al-Gareeb AI, K Al-Buhadiliy A, De Waard M, Sabatier JM, Khan Khalil AA, Saad HM, Batiha GE. Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke. Biomedicines 2022;10:2032. [PMID: 36009579 DOI: 10.3390/biomedicines10082032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Al-kuraishy HM, Al-gareeb AI, Al-hamash SM, Cavalu S, El-bouseary MM, Sonbol FI, Batiha GE. Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection. Front Med 2022;9:876017. [DOI: 10.3389/fmed.2022.876017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kurashima CK, Ng PK, Kendal-Wright CE. RAGE against the Machine: Can Increasing Our Understanding of RAGE Help Us to Battle SARS-CoV-2 Infection in Pregnancy? Int J Mol Sci 2022;23:6359. [PMID: 35742804 DOI: 10.3390/ijms23126359] [Reference Citation Analysis]